- Global Pharma News & Resources

Global Predictive Genetic Testing Market: Full Year 2019 Results | Estimated To Be Worth USD 3,800 Million In 2020 And Is Projected To Reach USD 27,120 Million By 2027

Proficient Market delivers key insights on the Global Predictive Genetic Testing Market in its published report, which includes global industry analysis, size, share, growth, trends, and forecast for 2019 –2027.

According to the report, Global Predictive Genetic Testing Market in 2020 stood at USD 3,800 million and is expected to reach USD 27,120 million by 2027 growing at a CAGR of 13.9% from 2020 to 2027.

Predictive genetic testing is majorly implemented on next-generation sequencing (NGS) platforms and is used to predict future risks by providing information on an individual’s chromosomes and genetic mutations. It is widely used in clinical practices and translational research for predicting the risk of diseases such as neurodegenerative diseases and cancer. Common disorders include Huntington’s disease, cystic fibrosis, phenylketonuria, Down’s syndrome, breast cancer, and sickle cell anemia.

This Report will help you to understand the Volume, growth with Impacting Trends. Click here To get SAMPLE PDF (Including Full TOC, Table & Figures):

Predictive Genetic Testing Market Key Players: The research study includes profiles of leading companies operating in the global predictive genetic testing market. Key players profiled in the report include:

23andMe Inc.
Ambry Genetics
Biocartis Group NV
Bio-Helix Co. Ltd.
bioMerieux SA
Blueprint Genetics
Counsyl Inc.
deCODE Genetics
Genomic Health Inc.
Genomictree Inc.
HTG Molecular Diagnostics Inc.
Illumina Inc.
Invitae Corporation

Access Full Report, here:

In July 2018, 23andMe Inc. entered into collaboration with GlaxoSmithKline plc. in order to discover novel targets for elucidation of disease progression pathways and develop therapies for disease eradication.

Drivers for the Global Predictive Genetic Testing Market: Growing automation in sequencing methodologies, along with introduction of efficient and rapid genomic sequencing procedures, is anticipated to boost advances in predictive genetic tests based on the NGS principle. Moreover, higher penetration of outsourcing has resulted in the emergence of several companies that are engaged in providing ‘sequencing-as-a-service’ or range of sample-to-insight services.

Opportunities for the Global Predictive Genetic Testing Market: Technological advancements in genetic testing will propel the global market demand in the forecast timeframe. Further, increased R&D efforts enable fast and cost-effective sequencing of DNA.

Region Wise, Global Predictive Genetic Testing Market Analysis: North America dominated the market by revenue owing to presence of several players based in U.S. Additionally, high awareness level, prevalence of chronic diseases, and high adoption of new technologies makes North America as maximum shareholder of the market in terms of regional analysis. However, Asia Pacific is anticipated to grow at a significant rate due to the growing population, rise in disposable income, increasing demand for genetic testing, prevalence of unhealthy lifestyles, and mounting government intervention in the development of health care infrastructure.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert@

Global Predictive Genetic Testing Market: Product analysis
Predictive Testing
Consumer Genomics
Wellness Genomics

On the basis of type, Predictive Testing accounted for largest share of total revenue generated. This is attributable to the growth in consciousness among people regarding health and increase in incidences of mortality rate due to the genetic diseases across the world.

Global Predictive Genetic Testing Market: Application analysis
Breast and Ovarian Cancer
ardiovascular screening
Diabetic Screening and Monitoring
Colon Cancer

The demand of Global Predictive Genetic Testing Market is highest from Breast and Ovarian Cancer. This is because of the increasing incidence of breast cancer globally and initiatives taken by governmental organizations to reduce morbidity rate caused by breast cancer.

Global Predictive Genetic Testing Market: Region analysis
North America: U.S., Canada, Mexico
Europe: U.K., France, Germany, Spain, Italy, Rest of Europe
Asia Pacific: China, Japan, South Korea, ASEAN, India
Rest of Asia Pacific: Latin America, Brazil, Argentina, Colombia, Rest of L.A.
Middle East and Africa: Turkey, GCC, UAE, South Africa, Rest of Middle East

The report can be customized as per client requirements. For further queries, you can contact us on or +1-773-800-2974. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

Read the full press release and latest news of this report, here:

About Us:
Proficient Market is the leading research company offering both tactical and strategic support to all our customers. Customer satisfaction is our goal and that is why, we have a team of skilled and experienced specialist with the ability to do data mining, information management, and revenue enhancement solutions to ensure that our clients make informed decisions when coming to investing in the market. Our happiness is when we help our clients grow their business, strengthen the brands and educate their members or consumers through the ever new fun research methods developed by our team.

Contact Us:
Proficient Market
1st Floor, Harikrishna Building,
Samarth Nagar, New Sanghvi,
Pune- 411027 India
Tel: +91-8149441100 (GMT Office Hours)
USA: +17738002974

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at

Editor Details

Last Updated: 02-Apr-2020